Enhanced glucose tolerance in the Brattleboro rat

Biochemical and Biophysical Research Communications

Volumn 405, Issue 1, 2011, Pages 64-67

  Nakamura, Kazuaki ^a   Yamashita, Tatsuya ^b   Fujiki, Hiroyuki ^b   Aoyagi, Toshinori ^a   Yamauchi, Junji ^a   Mori, Toyoki ^b   Tanoue, Akito ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Brattleboro rat; Glucose homeostasis; Glucose tolerance; Insulin sensitivity; Vasopressin; Vasopressin receptor

Indexed keywords

ARGIPRESSIN; GLUCOSE; INSULIN; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V1B RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRATTLEBORO RAT; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT;

ANIMALS; ARGININE VASOPRESSIN; BLOOD GLUCOSE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; MALE; MICE; RATS; RATS, BRATTLEBORO; RECEPTORS, VASOPRESSIN;

MUS; RATTUS;

EID: 79551490001     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.12.126     Document Type: Article

References (29)

1. Michell R.H., Kirk C.J., Billah M.M. Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem. Soc. Trans. 1979, 7:861-865.
2. Birnbaumer M. Vasopressin receptors. Trends Endocrinol. Metab. 2000, 11:406-410.
3. Fujiwara Y., Hiroyama M., Sanbe A., Aoyagi T., Birumachi J., Yamauchi J., Tsujimoto G., Tanoue A. Insulin hypersensitivity in mice lacking the V1b vasopressin receptor. J. Physiol. 2007, 584:235-244.
4. Hiroyama M., Aoyagi T., Fujiwara Y., Birumachi J., Shigematsu Y., Kiwaki K., Tasaki R., Endo F., Tanoue A. Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol. Endocrinol. 2007, 21:247-258.
5. Oshikawa S., Tanoue A., Koshimizu T.A., Kitagawa Y., Tsujimoto G. Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological/knockout approach. Mol. Pharmacol. 2004, 65:623-629.
6. Thibonnier M. Vasopressin and blood pressure. Kidney Int. Suppl. 1988, 25:S52-S56.
7. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.A., Mori T., Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J. Clin. Invest. 2004, 113:302-309.
8. Aoyagi T., Izumi Y., Hiroyama M., Matsuzaki T., Yasuoka Y., Sanbe A., Miyazaki H., Fujiwara Y., Nakayama Y., Kohda Y., Yamauchi J., Inoue T., Kawahara K., Saito H., Tomita K., Nonoguchi H., Tanoue A. Vasopressin regulates the renin-angiotensin-aldosterone system via V1a receptors in macula densa cells. Am. J. Physiol. Renal Physiol. 2008, 295:F100-F107.
9. Fujiwara Y., Hiroyama M., Sanbe A., Yamauchi J., Tsujimoto G., Tanoue A. Mutual regulation of vasopressin- and oxytocin-induced glucagon secretion in V1b vasopressin receptor knockout mice. J. Endocrinol. 2007, 192:361-369.
10. Hiroyama M., Aoyagi T., Fujiwara Y., Oshikawa S., Sanbe A., Endo F., Tanoue A. Hyperammonemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume. J. Physiol. 2007, 581:1183-1192.
11. Aoyagi T., Birumachi J., Hiroyama M., Fujiwara Y., Sanbe A., Yamauchi J., Tanoue A. Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice. Endocrinology 2007, 148:2075-2084.
12. Nakamura K., Aoyagi T., Hiroyama M., Kusakawa S., Mizutani R., Sanbe A., Yamauchi J., Kamohara M., Momose K., Tanoue A. Both V(1A) and V(1B) vasopressin receptors deficiency result in impaired glucose tolerance. Eur. J. Pharmacol. 2009, 613:182-188.
13. Bardoux P., Martin H., Ahloulay M., Schmitt F., Bouby N., Trinh-Trang-Tan M.M., Bankir L. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats. Proc. Natl. Acad. Sci. USA 1999, 96:10397-10402.
14. Zelena D., Filaretova L., Mergl Z., Barna I., Toth Z.E., Makara G.B. Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E243-E250.
15. Yarkov A., Montero S., Lemus M., Roces de Alvarez-Buylla E., Alvarez-Buylla R. Arginine-vasopressin in nucleus of the tractus solitarius induces hyperglycemia and brain glucose retention. Brain Res. 2001, 902:212-222.
16. Hems D.A., Whitton P.D. Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver. Biochem. J. 1973, 136:705-709.
17. Skol HW V.H. The Brattleboro rat. Ann. NY Acad. Sci. 1982, 394:1-828.
18. Promeneur D., Kwon T.H., Frokiaer J., Knepper M.A., Nielsen S. Vasopressin V(2)-receptor-dependent regulation of AQP2 expression in Brattleboro rats. Am. J. Physiol. Renal Physiol. 2000, 279:F370-F382.
19. Yun J., Schoneberg T., Liu J., Schulz A., Ecelbarger C.A., Promeneur D., Nielsen S., Sheng H., Grinberg A., Deng C., Wess J. Generation and phenotype of mice harboring a nonsense mutation in the V2 vasopressin receptor gene. J. Clin. Invest. 2000, 106:1361-1371.
20. Yasui M., Zelenin S.M., Celsi G., Aperia A. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. Am. J. Physiol. 1997, 272:F443-F450.
21. Qi L., Saberi M., Zmuda E., Wang Y., Altarejos J., Zhang X., Dentin R., Hedrick S., Bandyopadhyay G., Hai T., Olefsky J., Montminy M. Adipocyte CREB promotes insulin resistance in obesity. Cell Metab. 2009, 9:277-286.
22. Acher R. Neurohypophysial peptide systems: processing machinery, hydroosmotic regulation, adaptation and evolution. Regul. Pept. 1993, 45:1-13.
23. Argiolas A. Oxytocin stimulation of penile erection. Pharmacology, site, and mechanism of action. Ann. NY Acad. Sci. 1992, 652:194-203.
24. Carmichael M.S., Warburton V.L., Dixen J., Davidson J.M. Relationships among cardiovascular, muscular, and oxytocin responses during human sexual activity. Arch. Sex Behav. 1994, 23:59-79.
25. Heinrichs M., von Dawans B., Domes G. Oxytocin, vasopressin, and human social behavior. Front. Neuroendocrinol. 2009, 30:548-557.
26. Camerino C. Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring) 2009, 17:980-984.
27. Takayanagi Y., Kasahara Y., Onaka T., Takahashi N., Kawada T., Nishimori K. Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport 2008, 19:951-955.
28. Boer G.J., van Heerikhuize J., van der Woude T.P. Elevated serum oxytocin of the vasopressin-deficient Brattleboro rat is present throughout life and is not sensitive to treatment with vasopressin. Acta Endocrinol. (Copenh.) 1988, 117:442-450.
29. Nakamura K., Fujiwara Y., Mizutani R., Sanbe A., Miyauchi N., Hiroyama M., Yamauchi J., Yamashita T., Nakamura S., Mori T., Tsujimoto G., Tanoue A. Effects of vasopressin V1b receptor deficiency on adrenocorticotropin release from anterior pituitary cells in response to oxytocin stimulation. Endocrinology 2008, 149:4883-4891.